Search clinical trials for: Vehicle of Ophthalmic Loteprednol Etabonate

Total 1595 results

Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery

Ocular Inflammation

United States
Bausch & Lomb Incorporated

Completed

LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Pain | Ocular Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

Dry Eye

United States
University of California, San Diego
Bausch & Lomb Incorporated; Shiley Eye Center

Withdrawn

Efficacy of Loteprednol Ointment Following Eyelid Surgery

Post-operative Healing Following Blepharoplasty and Ptosis Repair

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Ocular Inflammation

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge

Allergic Conjunctivitis

United States
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease (STRIDE 2)

Dry Eye Syndromes | Keratoconjunctivitis Sicca

United States
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation (Hawaii-1)

Ocular Infections, Irritations and Inflammations

United States
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease (STRIDE 1)

Dry Eye Syndromes | Keratoconjunctivitis Sicca

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Pain | Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery

Pain | Inflammation

United States
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease (Kauai)

Dry Eye Syndromes | Keratoconjunctivitis Sicca

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery

Pain | Inflammation

United States
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

Post Surgical Ocular Inflammation and Pain

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Pain | Inflammation | Cataract

United States
Bausch Health Americas, Inc.

Completed

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Eye Pain

United States
Bausch & Lomb Incorporated

Completed

Pediatric Zylet Safety and Efficacy Study

Hordeolum | Chalazion

United States
Kala Pharmaceuticals, Inc.

Completed

Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema (Molokini)

Diabetic Macular Edema | Retinal Vein Occlusion

United States
Kala Pharmaceuticals, Inc.

Completed

Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease (Maui)

Blepharitis

United States
Price Vision Group
Kala Pharmaceuticals, Inc.

Completed

Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Corneal Edema | Corneal Endothelial Dystrophy

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

Conjunctivitis

United States
Allergan

Completed

A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin

Ocular Hypertension

United States
Toyos Clinic

Completed

Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery

Inflammation | Pseudophakia

United States
Edward Holland, MD

Withdrawn

A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®

Dry Eye Disease

United States
Virginia Polytechnic Institute and State University
Vistar Eye Center

Recruiting

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Age-Related Macular Degeneration

United States
Sandoz

Completed

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

Inflammation Following Ocular Surgery

Canada
Meir Medical Center

Unknown

Topical Steroid Treatment For Dry Eye

Dry Eye

Israel
Yonsei University

Completed

Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate

Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)

Korea, Republic of
Hom, Milton M., OD, FAAO
Bausch & Lomb Incorporated

Unknown

Use of Loteprednol for Contact Lens Intolerance and Dryness

Contact Lenses Dryness

United States
Southern California College of Optometry at Marshall...

Completed

Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Illinois College of Optometry

Completed

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

Allergy | Dry Eye | Keratoconus

United States
Bausch & Lomb Incorporated

Completed

Zylet vs TobraDex in Blepharokeratoconjunctivitis

Blepharokeratoconjunctivitis

United States
University of Rochester
Bausch & Lomb Incorporated

Completed

Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax

Sjogren's Disease

United States
Tufts Medical Center

Completed

The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED

Dry Eye Disease

United States
Bausch & Lomb Incorporated
Synteract, Inc.

Completed

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

Keratoconjunctivitis Sicca

United States
Bausch & Lomb Incorporated

Completed

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations

Healthy

United States
Massachusetts Eye and Ear Infirmary
Bausch & Lomb Incorporated

Completed

Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis (ZvL)

Meibomian Gland Dysfunction | Posterior Blepharitis

United States
Bausch & Lomb Incorporated

Completed

Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation

Pharmacokinetics

United States
Research Insight LLC

Completed

Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization (CLEAN)

Dry Eye

United States
Sylentis, S.A.

Completed

HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)

Dry Eye Disease

Spain, Portugal, Italy, Estonia, Germany, Slovakia
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis

Vernal Keratoconjunctivitis
Aldeyra Therapeutics, Inc.

Completed

The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

Dry Eye | Dry Eye Syndromes

United States
Second Affiliated Hospital of Nanchang University

Completed

Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial

Vernal Keratoconjunctivitis | Cyclosporine 0.05% Eye Drops

China
Khon Kaen University

Completed

Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing

Epithelial Defect After Phototherapeutic Keratectomy

Thailand
Adapt Produtos Oftalmológicos Ltda.

Withdrawn

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Ocular Inflammation | Keratitis | Conjunctivitis, Bacterial | Infection Associated Blepharitis

Brazil
Clinical Research Center of Florida
Ocular Therapeutix, Inc.

Completed

DEXTENZA Therapy for Treatment of Allergic Conjunctivitis

Bilateral Conjunctivitis (Disorder)

United States
Medical University of South Carolina

Completed

Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation

Cataract Extraction

United States
Dr Salouti Eye Research Center
Shiraz University of Medical Sciences

Unknown

Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study

Must be PRK Candidate
Ophthalmic Consultants of Long Island
Bausch & Lomb Incorporated

Completed

Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis

Keratoconjunctivitis Sicca | Dry Eye Disease

United States
Mitotech, SA
ORA, Inc.

Completed

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

Keratoconjunctivitis Sicca

United States

Search clinical trials for: Vehicle of Ophthalmic Loteprednol Etabonate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations